Epidemiology Intelligence
Size your market accurately with comprehensive epidemiology data
The complete epidemiology market picture
Confidently size your market and understand target patient populations using a single source of epidemiology intelligence, featuring a unique combination of incidence and prevalence literature review, in-depth disease-specific forecasts and U.S. claims-based insights.
Benchmark
Validate
Estimate
Broad and deep coverage of disease epidemiology
Extensive incidence and prevalence insights
Conduct thorough market assessment with comprehensive coverage across 1200+ diseases and procedures.
In-depth expert analysis
Dive deep into expert disease-specific epidemiology analysis and 20-year forecasts across 171 countries and 220 indications.
U.S. claims-based insights
Leverage expanded patient segmentation and granularity with insights sourced from Clarivate U.S. Real-World Data.
Accurate market sizing to shape your strategy
Benchmark forecasts effectively
Quantify the total potential and addressable market and understand how patient populations change over time. Estimate drug-treated and drug-treatable populations with 20-year epidemiology forecasts spanning 45 countries, plus additional forecasts across 171 countries with our proprietary Extrapolated World Coverage dashboard.
Quick and efficient market sizing
Make preliminary market sizing assessments across thousands of indications, including niche and rare diseases. Leverage a trusted literature review of diseases, procedures, symptoms and other health issues for incidence, prevalence, morbidity, mortality, comorbidity, treated or diagnosed rates and cost.
Identify growth opportunities
Make empowered decisions on a potential asset’s lucrativeness in a particular market based on patient population growth dynamics, and understand disease stratification in a market by attributes like diagnosed and drug-treated status, stage of a disease, severity etc.
